[HTML][HTML] Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial
A Al-Chalabi - Lancet Neurol, 2013 - thelancet.com
Background Lithium has neuroprotective effects in cell and animal models of amyotrophic
lateral sclerosis (ALS), and a small pilot study in patients with ALS showed a significant …
lateral sclerosis (ALS), and a small pilot study in patients with ALS showed a significant …
[PDF][PDF] Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial
A Al-Chalabi - Lancet Neurol, 2013 - researchgate.net
Background Lithium has neuroprotective effects in cell and animal models of amyotrophic
lateral sclerosis (ALS), and a small pilot study in patients with ALS showed a significant …
lateral sclerosis (ALS), and a small pilot study in patients with ALS showed a significant …
Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial
C Allen, C Counsell, A Farrin, A Al-Chalabi… - Lancet …, 2013 - eprints.ncl.ac.uk
Background Lithium has neuroprotective effects in cell and animal models of amyotrophic
lateral sclerosis (ALS), and a small pilot study in patients with ALS showed a significant …
lateral sclerosis (ALS), and a small pilot study in patients with ALS showed a significant …
Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial
A Al-Chalabi - Lancet Neurol, 2013 - thelancet.com
Background Lithium has neuroprotective effects in cell and animal models of amyotrophic
lateral sclerosis (ALS), and a small pilot study in patients with ALS showed a significant …
lateral sclerosis (ALS), and a small pilot study in patients with ALS showed a significant …
[PDF][PDF] Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial
A Al-Chalabi - Lancet Neurol, 2013 - Citeseer
Background Lithium has neuroprotective effects in cell and animal models of amyotrophic
lateral sclerosis (ALS), and a small pilot study in patients with ALS showed a significant …
lateral sclerosis (ALS), and a small pilot study in patients with ALS showed a significant …
[HTML][HTML] Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial
UKMND-LiCALS Study Group - The Lancet. Neurology, 2013 - ncbi.nlm.nih.gov
Background Lithium has neuroprotective effects in cell and animal models of amyotrophic
lateral sclerosis (ALS), and a small pilot study in patients with ALS showed a significant …
lateral sclerosis (ALS), and a small pilot study in patients with ALS showed a significant …
Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial
A Al-Chalabi, CM Allen, CE Counsell… - The Lancet …, 2013 - abdn.pure.elsevier.com
Background: Lithium has neuroprotective effects in cell and animal models of amyotrophic
lateral sclerosis (ALS), and a small pilot study in patients with ALS showed a significant …
lateral sclerosis (ALS), and a small pilot study in patients with ALS showed a significant …
Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial.
K Morrison, S Dhariwal, R Hornabrook, L Savage… - Lancet …, 2013 - ora.ox.ac.uk
BACKGROUND: Lithium has neuroprotective effects in cell and animal models of
amyotrophic lateral sclerosis (ALS), and a small pilot study in patients with ALS showed a …
amyotrophic lateral sclerosis (ALS), and a small pilot study in patients with ALS showed a …
[HTML][HTML] Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial
UKMND-LiCALS Study Group - The Lancet Neurology, 2013 - Elsevier
BACKGROUND: Lithium has neuroprotective effects in cell and animal models of
amyotrophic lateral sclerosis (ALS), and a small pilot study in patients with ALS showed a …
amyotrophic lateral sclerosis (ALS), and a small pilot study in patients with ALS showed a …
Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial
KE Morrison, S Dhariwal, R Hornabrook… - Lancet …, 2013 - pure.qub.ac.uk
Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre,
randomised, double-blind, placebo-controlled trial — Queen's University Belfast Skip to main …
randomised, double-blind, placebo-controlled trial — Queen's University Belfast Skip to main …